FT : Amazon joins Big Tech bond rush with $12bn debt sale

Amazon joins Big Tech bond rush with $12bn debt sale
Ecommerce giant’s first US bond in three years comes as it cranks up spending on artificial intelligence infrastructure

Amazon is seeking to raise $12bn in its first US bond sale in three years, becoming the latest big tech group to turn to debt markets to fund a spending spree on artificial intelligence infrastructure.

The Seattle-based ecommerce and cloud computing giant launched the bond sale on Monday and is targeting approximately $12bn across about six investment-grade bonds, according to a person close to the deal.

Goldman Sachs, JPMorgan Chase and Morgan Stanley are managing the sale, according to regulatory filings.

Amazon said: “Like all companies, we regularly evaluate our operating plan and make financing decisions — like entering into a credit agreement or issuing bonds — accordingly. The proceeds from this issuance will be used to support business investments, fund future capital expenditures, and repay upcoming debt maturities.”

Big tech companies are in an expensive arms race to build data centres that can power AI. In recent months, many have pivoted to funding large construction projects with debt rather than spending their cash reserves.

Google parent Alphabet sold $25bn of bonds earlier this month, Meta sold $30bn in the largest corporate bond sale so far this year in October, and Oracle sold $18bn of bonds in September.

US companies have issued more than $200bn worth of corporate bonds this year to fund AI-related infrastructure projects, which analysts have warned could “flood” debt markets and store up new risks for credit investors.

The borrowing spree is expected to push US issuance of corporate bonds to a record $1.8tn next year, according to JPMorgan. Goldman Sachs had previously estimated that the “jumbo” tech bond sales accounted for more than a quarter of all net supply of US corporate debt this year.

Amazon’s cloud computing unit Amazon Web Services is the world’s largest provider of leased computing power. Like its rivals, it has expanded investment on infrastructure amid a boom in demand for AI services. Capital expenditures rose 61 per cent to $34.2bn in the third quarter of 2025, bringing the total it has spent so far this year to $89.9bn.

Those investments have doubled the amount of computing capacity Amazon has access to since 2022 and it is planning to double it again by 2027, according to comments by chief executive Andy Jassy during its most recent earnings call.

It signed a $38bn deal to supply computing power to OpenAI this month, giving the start-up access to hundreds of thousands of its Nvidia chips for seven years.

The issuance of AI bonds has hit prices in recent weeks, as investors anticipate hundreds of billions of debt coming in the next few years.

“The sudden onslaught of supply is weighing a bit on the market. This AI issuance is coming fast and furious . . . These may be trading at tight spreads, but they promise to reshape the entire market,” said Robert Tipp, head of global bonds at PGIM, explaining that the surge in issuance would probably drive yields on longer-dated debt significantly higher.

FT : UK to ban resale of tickets above face value for live events

UK to ban resale of tickets above face value for live events
Aggressive crackdown on touts comes after backlash over cost of watching live music and sport

UK ministers plan to ban the resale of tickets for live events above their original cost, in an aggressive crackdown on touts and resellers who sharply increase the price of admission to concerts and sports events.

In plans to be announced on Wednesday, reselling a ticket above face value will be outlawed, government and industry figures told the Financial Times.

The big profits made by resellers were highlighted last summer when thousands of Oasis fans complained about the cost of buying tickets to see the rock band this year.

Some tickets for Oasis shows at Wembley Stadium in London were listed at more than £4,000 — well above their original value.

New legislation being drawn up by the Labour government will also cap service fees charged by resale platforms to stop price limits being undermined by the addition of hidden costs to a ticket.

Ministers want to make it illegal for people to resell more tickets than they were entitled to buy in the initial sale, in an attempt to end industrial-scale touting, in which bots are used to buy up vast numbers of tickets.

The government declined to comment.

The proposed changes would be a blow to popular secondary ticket platforms such as Viagogo and StubHub. StubHub’s shares dropped more than 14 per cent in New York afternoon trading on Monday.

Such sites, which have become increasingly popular in recent years, have argued that proposals to limit price increases risk creating an illegal black market for tickets.

Some MPs and industry groups have also argued this would lead to fewer consumer protections.

But fans have been left frustrated by intermediaries selling tickets for increasingly high prices. 

The outcry over tickets for the Oasis reunion led ministers to launch a consultation in January into options for a crackdown, initially focused on a cap at 30 per cent above the original face value of a ticket. 

But Wednesday’s announcement will go further, with a total ban on sales “above original cost” for tickets to concerts, sport, comedy and theatre. 

The new rules are expected to shave up to £40 from the average cost of a resale ticket, saving tens of millions of pounds for fans every year.

In a statement last week, artists such as Coldplay, Dua Lipa, Mogwai and Radiohead called on Prime Minister Sir Keir Starmer to cap ticket resale price and tackle “extortionate and pernicious” websites used by touts.

Touts cost gig-goers about £145mn a year in elevated prices, according to Let’s Stamp it Tout, a campaign started by Virgin Media O2, which is also part of the FanFair Alliance, comprising managers and teams for artists including Arctic Monkeys and Ed Sheeran.

It said that one in five tickets ended up on a resale platform.

Analysis by Virgin Media O2 of resale sites this summer found that tickets for acts such as such as Diana Ross, Oasis and Lady Gaga in London were being resold for up to 490 per cent on average above face value.

Its research found that traders selling more than 100 tickets a year accounted for more than 82 per cent of tickets on resale sites for a Billie Eilish concert, highlighting what it called the extent of the work of “industrial-scale” touts.

REuters : EDF, OpCore to develop 4-billion-euro data centre in France

EDF, OpCore to develop 4-billion-euro data centre in France

Nov 17 (Reuters) - French utility EDF and OpCore, a joint venture between telecoms group Iliad and InfraVia Capital Partners, have entered into exclusive negotiations to develop a hyperscale data centre, the companies said on Monday.

The project, which would be located on the site of EDF’s former coal-fired plant at Montereau-Vallee-de-la-Seine, is expected to cost around 4 billion euros ($4.64 billion) and would create one of Europe’s largest computing hubs with several hundred megawatts of capacity.

Europe's old power plant sites are increasingly being repurposed for data centres to meet surging demand for AI computing, leveraging existing grid connections and industrial land to speed up deployment and cut costs.

"This investment shows that France intends to lead the artificial intelligence revolution," French Economy Minister Roland Lescure said in a statement. “We are reaffirming our determination to reindustrialise the country, create jobs ... and make France a major digital power."

A first phase is scheduled to come online in 2027 under France’s fast-track grid connection scheme.

EDF launched a call for interest earlier this year to repurpose industrial land for strategic digital infrastructure.

The Montereau site, shut down in 2004, will be redeveloped with a focus on energy efficiency and environmental standards, the companies said.

>>> US Research Calls I

Research Calls I
  • Upgrades
    • American Electric Power (AEP) upgraded to Buy from Hold at Jefferies, tgt $137
    • Apogee Enterprises (APOG) upgraded to Buy from Neutral at DA Davidson, tgt $47
    • Ball Corp. (BALL) upgraded to Buy from Neutral at BofA Securities, tgt $61
    • Blackstone Mortgage Trust (BXMT) upgraded to Outperform from Market Perform at Keefe, Bruyette & Woods, tgt $21
    • Block Inc. (XYZ) upgraded to Hold from Sell at Truist Securities, tgt $68
    • Expeditors International (EXPD) upgraded to Buy from Neutral at UBS, tgt $166
    • Gap Inc. (GAP) upgraded to Overweight from Equal Weight at Barclays, tgt $30
    • O-I Glass (OI) upgraded to Buy from Neutral at BofA Securities, tgt $17
    • Sylvamo Corp. (SLVM) upgraded to Buy from Underperform at BofA Securities, tgt $59
    • The Vita Coco Co. (COCO) upgraded to Buy from Neutral at BofA Securities, tgt $48
    • Yum! Brands (YUM) upgraded to Buy from Hold at TD Cowen, tgt $173
    • Rubrik Inc. (RBRK) upgraded to Outperform from Neutral at Mizuho, tgt $97
  • Downgrades
    • Adverum Biotechnologies (ADVM) downgraded to Neutral from Buy at H.C. Wainwright, tgt $5
    • Ardent Health Partners (ARDT) downgraded to Sector Weight from Overweight at KeyBanc
    • Celcuity Inc. (CELC) downgraded to Neutral from Buy at H.C. Wainwright, tgt $94
    • Century Therapeutics (IPSC) downgraded to Market Perform from Outperform at Leerink Partners, tgt $2
    • Cidara Therapeutics (CDTX) downgraded to Equalweight from Overweight at Morgan Stanley, tgt $221.5
    • Cidara Therapeutics (CDTX) downgraded to Neutral from Overweight at JPMorgan, tgt $221.5
    • Cidara Therapeutics (CDTX) downgraded to Sector Perform from Outperform at RBC Capital, tgt $221.5
    • Corebridge Financial (CRBG) downgraded to Equal weight from Overweight at Morgan Stanley, tgt $33
    • Dell (DELL) downgraded to Underweight from Overweight at Morgan Stanley, tgt $110
    • HP Inc. (HPQ) downgraded to Underweight from Equal Weight at Morgan Stanley, tgt $24
    • HP Enterprise (HPE) downgraded to Equal weight from Overweight at Morgan Stanley, tgt $25
    • Karat Packaging (KRT) downgraded to Underperform from Buy at BofA Securities, tgt $22
    • Potlatch (PCH) downgraded to Underperform from Buy at BofA Securities, tgt $46
    • Sealed Air (SEE) downgraded to Hold from Buy at Stifel, tgt $45
    • Weyerhaeuser (WY) downgraded to Neutral from Buy at BofA Securities
  • Others
    • Akamai Technologies (AKAM) initiated at Outperform at Oppenheimer, tgt $100
    • Alto Neuroscience (ANRO) initiated at Buy at BTIG, tgt $27
    • Builders FirstSource (BLDR) initiated at Equal Weight at Wells Fargo, tgt $115
    • TopBuild Corp. (BLD) initiated with an Overweight at Wells Fargo, tgt $500
    • Fastly (FSLY) initiated at Perform at Oppenheimer
    • Installed Building Products (IBP) initiated at Equal Weight at Wells Fargo, tgt $275
    • Masimo Corp. (MASI) initiated at Neutral at BofA Securities, tgt $162
    • NetApp (NTAP) initiated at Perform at Oppenheimer
    • Nutanix (NTNX) initiated at Outperform at Oppenheimer, tgt $90
    • Ovid Therapeutics (OVID) initiated at Outperform at Leerink Partners, tgt $5
    • Pure Storage (PSTG) initiated at Outperform at Oppenheimer, tgt $120
    • Pacira Pharmaceuticals (PCRX) initiated at Buy at H.C. Wainwright, tgt $38
    • Rubrik (RBRK) initiated at Perform at Oppenheimer
    • Stagwell Inc. (STGW) initiated at Buy at Seaport Global, tgt $10
    • SunocoCorp LLC (SUNC) initiated at Outperform at Raymond James, tgt $70
    • TAT Technologies (TATT) resumed at Buy at Benchmark, tgt $53
    • Vivos Therapeutics (VVOS) initiated at Buy at H.C. Wainwright, tgt $7

>>> Europe : Brokers Upgrades & Downgrades - 17th of November 2025 V3(++)

>>> Up
* Amrize Raised to Buy at Bank Vontobel; PT 51 Swiss francs (+)
* Exail Technologies Raised to Buy at TP ICAP Midcap; PT 99 euros (+)
* Gap Raised to Overweight at Barclays; PT $30
* Heidelberg Materials Raised to Overweight at Barclays
* Latour Raised to Hold at Handelsbanken; PT 245 kronor (++)
* Lemonsoft Raised to Accumulate at Inderes; PT 7.10 euros
* Nagarro Raised to Outperform at Oddo BHF; PT 83 euros (+)
* Nokia Raised to Accumulate at OP Corporate Bank; PT 6.50 euros (++)
* PVA TePla Raised to Buy at SMC Research; PT 29 euros (++)
* Richemont PT Raised at Morgan Satnley from 183 to 192 CHF (++)
* Royal Unibrew Price Target Raised to DKK 700 from DKK 690 by SEB
* RS Group Raised to Buy at Rothschild & Co Redburn; PT 760 pence
* Sea Ltd ADRs Raised to Buy at Phillip Secs; PT $170
* Siemens Energy Raised to Outperform at Grupo Santander
* Voestalpine Raised to Buy at UBS; PT 43 euros (++)

>>> Down
* AF Gruppen Cut to Hold at Kepler Cheuvreux; PT 196 kroner (++)
* ArcelorMittal Cut to Neutral at UBS; PT 35.40 euros (++)
* Azimut Cut to Hold at Deutsche Bank; PT 35 euros
* BNP Paribas Cut to Hold at Deutsche Bank; PT 78 euros
* Buzzi SpA Cut to Equal-Weight at Barclays; PT 55 euros
* Dell Technologies Cut to Underweight at Morgan Stanley; PT $110
* Endesa Cut to Neutral at JPMorgan; PT 32.50 euros
* HP Enterprise Cut to Equal-Weight at Morgan Stanley; PT $25
* HP Inc. Cut to Underweight at Morgan Stanley; PT $24
* OMV Cut to Hold at Berenberg; PT 53 euros (+)
* Sealed Air Cut to Hold at Stifel; PT $45
* Stainless Tankers Cut to Neutral at Clarksons; PT 45 kroner (++)

>>> Initiation
* Anglo American Reinstated Hold at Investec; PT 3,116.17 pence (+)
* Glencore Reinstated Buy at Investec; PT 467.43 pence (+)
* Interparfums Rated New Buy at Marex; PT 60 euros (++)
* Prosafe Rated New Hold at Arctic Securities; PT 4 kroner
* Smith & Nephew Reinstated Buy at Kepler Cheuvreux (++)
* TP ICAP Rated New Buy at Cavendish; PT 342 pence

>>> Call
* Morgan Stanley Lifts Target for European Stocks, Sees US Boost (+)
* Nagarro Surges After Oddo Upgrades on Strong Results, Outlook (++)
* Siegfried Shares Slide as Vontobel Says CFO Change a Surprise (++)
* Tonies Nudges Higher as Oddo BHF Lifts Target, Sees Strong 4Q (++)

>>> US Gapping up

Gapping up
In reaction to earnings/guidance
:
  • QUBT +14.7%, NIU +6.4%, YSG +4.7%, SOHU +4.7%, HIVE +1.8%, BRC +1.3%,
Other news:
  • ZYME +35% (HERIZON-GEA-01 Phase 3 Results)
  • RPTX +24.2% (enters into definitive agreement to be acquired by XenoTherapeutics)
  • JAZZ +21.1% (reports HERIZON-GEA-01 Phase 3 results supporting Ziihera)
  • SSP +19.3% (Sinclair (SBGI) acquired the Class A Common Stock in contemplation of a possible combination; discloses 8.2% active stake)
  • AVR +9.8% (presents data from 100 DurAVR THV patients at PCR london valves)
  • TNXP +9.5% (TONMYATM is now commercially available at pharmacies by prescription in the United States)
  • ESLT +8.3% (inks $2.3 bln international contract)
  • FIGR +5.1% (new Soros stake)
  • GOOGL +4.4% (new Berkshire Hathaway stake)
  • COCO +3.8% (comments on tariff relief impact)
  • QLGN +3.7% (shareholders approve full transition to AIxCrypto Holdings, Advancing AI × Web3 Strategy)
  • SE +3.3% (authorizes share buyback program)
  • SRDX +3% (FTC does not intend to appeal denial of injunction, order preventing closing set to expire today)
  • ONC +2.7% (reports Phase 3 results support ZIIHERA as HER2-Targeted Therapy-of-Choice and combination with TEVIMBRA and Chemotherapy as new Standard of Care in first-line HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma)
  • MASI +2.6% (wins $634 mln jury verdict against Apple (AAPL) for patent infringement)
  • NUVL +2.6% (topline pivotal data from ALKOVE-1 Clinical Trial of Neladalkib)
  • INDV +2.2% (new Soros stake)
  • MNRO +2% (new Icahn stake)
  • FUN +2% (new Jana Partners stake)
  • OGN +2% (Organon and Henlius secure FDA approval for POHERDY)
  • DNN +2% (expands strategic perimeter around Wheeler River through Multi-JV Deal with Skyharbour)
  • JBIO +1.9% (files for 16,125,269 share common stock offering by selling shareholders)
  • WALD +1.6% (sold its rights to the "Obagi" trademark in Japan to Rohto Pharma; Obagi Medical shares new clinical data on Obagi Hyaluronic Acid Injectables and Nu-Cil Scalp Serum at the 2025 American Society for Dermatologic Surgery Annual Meeting)
  • BILL +1.1% (new Starboard stake)

>>> US Gapping down

Gapping down
In reaction to earnings/guidance
:
  • XPEV -3.9%, ARMK -3.7%, IMTX -2%, ZK -0.9%
Other news:
  • WTF -3.7% (files for 5,359,719 ordinary share offering)
  • SEE -3% (to be acquired by CD&R for $10.3 billion)
  • ROCK -2.8% (has reached an agreement to acquire OmniMax International from funds managed by Strategic Value Partners, LLC and its affiliates for a cash purchase price of $1.335 bln)
  • LB -2.1% (2.5 mln secondary public offering of Class A shares by LandBridge Holdings LLC)
  • AVDL -1.4% (Avadel Pharmaceuticals' Board labels Lundbeck bid a 'Superior Proposal' amid ongoing Alkermes (ALKS) agreement)
  • OSIS -1.2% (announces its intention to offer, subject to market and other conditions, $400 mln aggregate principal amount of convertible senior notes due 2031)
  • AAPL -1% (decreased Berkshire Hathaway stake)
  • VEON -0.9% (commences $100 mln share repurchase program)

>>> US Early premarket gappers

Early premarket gappers
  • Gapping up:
    • ZYME +59.2%, JAZZ +31.2%, RPTX +24.8%, SSP +18%, QUBT +17.1%, AVR +14.9%, NIU +8%, ESLT +7.8%, FIGR +6.8%, NUVL +6.2%, HIVE +6.2%, QLGN +5.9%, GOOGL +4.7%, SE +3.8%, MASI +3.2%, SRDX +3.1%, JBIO +2.8%, UMAC +2.7%, OGN +2.1%, MNRO +2%, SBGI +1.9%, INDV +1.7%, FUN +1.6%, WALD +1.6%, DNN +1.6%, STUB +1.5%, BILL +1.2%, ONC +1.1%, SEZL +1%
  • Gapping down:
    • ARMK -7.2%, WTF -3.7%, XPEV -3.2%, YSG -2.6%, LB -1.9%, YMM -1.3%, LAMR -1.1%, VEON -0.9%, ZK -0.9%, SY -0.8%, AAPL -0.7%, NUE -0.5%